Peter Rahal, Co-founder and CEO of RXBar, says the company was founded on the transparency of its ingredients, and that purpose led to a $600 million buyout from Kellogg.
Rahal explains why ever ingredient in every product is in bold letters on the front of the package. When the company started out, "people would be like ‘well what is it?'” So they made the answer easy to find.
Rahal discusses RXBAR's $600 million sale to Kellogg, and the future direction of the company, where he will remain as CEO. We talk about the whirlwind the company's evolution has been, given that it was founded in 2013, when Rahal and his co-founder were both broke. Then we look ahead to what's next for the company after the Kellogg buyout.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
